CO5070601A1 - Suspencion peroral de meloxicam micronizado que cuenta con bajas proporciones de dioxido de silicio y un polimero hidrofilico como hidroxietilcelulosa, en un medio de dispercion constituido por una solucion reguladora en un rango de ph de 2 a 4 - Google Patents
Suspencion peroral de meloxicam micronizado que cuenta con bajas proporciones de dioxido de silicio y un polimero hidrofilico como hidroxietilcelulosa, en un medio de dispercion constituido por una solucion reguladora en un rango de ph de 2 a 4Info
- Publication number
- CO5070601A1 CO5070601A1 CO99018550A CO99018550A CO5070601A1 CO 5070601 A1 CO5070601 A1 CO 5070601A1 CO 99018550 A CO99018550 A CO 99018550A CO 99018550 A CO99018550 A CO 99018550A CO 5070601 A1 CO5070601 A1 CO 5070601A1
- Authority
- CO
- Colombia
- Prior art keywords
- acid
- pharmaceutically acceptable
- suspention
- peroral
- range
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Suspensión aplicable por vía oral de un principio activo farmacéuticamente del tipo de Fármacos No-Esteroides Anti-Inflamatorios (FNEAI) seleccionado a partir del ácido acetilsalicílico o un FNEAI de las siguientes categorías: a) un derivado de ácido propiónico seleccionado a partir de Ibuprofen, Naproxen, Flurbiprofen, Fenoprofen, Fenbufen, Ketoprofen, Indoprofen, Pirprofen, Carprofen, Oxaprozin, Pranoprofen, Miroprofen, Tioxaprofen, Suprofen, Alminoprofen, ácido tiaprofénico y Fluprofeno a las sales farmacéuticamente aceptables de los mismos, b) un derivado de ácido acético seleccionado a partir de Indomethacin, Sulindac, Tolmetin, Zomepirac, Nabumetone, Diclofenac, Fenclofenac, Alclofenac, Bromfenac, Ibufenac, Aceclofenac, Acemetacin, Fentiazac, Olidanac, Etodolac y Oxpinac, o las sales farmacéuticamente aceptables de los mismos, c) un derivado de ácido fenámico seleccionado a partir de ácido Mefenámico, ácido Meclofenámico, ácido Flupenámico, ácido Niflúmico y ácido Tolfenámico o las sales farmacéuticamente aceptables de los mismos, d) un derivado de ácido bifenilcarboxílico seleccionado a partir de Diflunisal y Flufenisal o las sales farmacéuticamente aceptables de los mismos, e) una enalcarboxamida ácida seleccionada a partir de Piroxicam, Tenoxicam, Lornoxicam y Meloxicam o las sales farmacéuticamente aceptables de los mismos, f) un aril heterociclo con sustituyentes metilsulfonilo o aminosulfonilo o una sal farmacéuticamente aceptable del mismo, y g) una sulfonamida ácida seleccionada a partir de Nimesulide o una sal farmacéuticamente aceptable de la misma, con un espectro de tamaño de grano suspendible en un medio de dispersión fisiológicamente inerte, en el cual el principio activo tiene una solubilidad menor de 500 (g/ml de manera que la suspensión no presenta ningún sabor específico perceptible, ... <EMI FILE="99018550_1" ID="1" IMF=JPEG >
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98105568A EP0945131A1 (de) | 1998-03-27 | 1998-03-27 | Perorale Wirkstoff-Suspension |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5070601A1 true CO5070601A1 (es) | 2001-08-28 |
Family
ID=8231651
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO99018550A CO5070601A1 (es) | 1998-03-27 | 1999-03-26 | Suspencion peroral de meloxicam micronizado que cuenta con bajas proporciones de dioxido de silicio y un polimero hidrofilico como hidroxietilcelulosa, en un medio de dispercion constituido por una solucion reguladora en un rango de ph de 2 a 4 |
Country Status (26)
Country | Link |
---|---|
EP (2) | EP0945131A1 (es) |
JP (1) | JP3323189B2 (es) |
KR (1) | KR100587208B1 (es) |
CN (1) | CN1150888C (es) |
AR (1) | AR016196A1 (es) |
AT (1) | ATE225648T1 (es) |
AU (1) | AU762464B2 (es) |
BR (1) | BR9909189A (es) |
CA (1) | CA2326048C (es) |
CO (1) | CO5070601A1 (es) |
DE (1) | DE59903023D1 (es) |
DK (1) | DK1066029T3 (es) |
ES (1) | ES2184428T3 (es) |
HK (1) | HK1034184A1 (es) |
HU (1) | HU228474B1 (es) |
IL (1) | IL137479A (es) |
MY (1) | MY124599A (es) |
NO (1) | NO321401B1 (es) |
NZ (1) | NZ507610A (es) |
PL (1) | PL192969B1 (es) |
PT (1) | PT1066029E (es) |
TR (1) | TR200002772T2 (es) |
TW (1) | TWI232759B (es) |
UY (1) | UY25443A1 (es) |
WO (1) | WO1999049845A1 (es) |
ZA (1) | ZA200003951B (es) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8231899B2 (en) | 1998-09-10 | 2012-07-31 | Nycomed Danmark Aps | Quick release pharmaceutical compositions of drug substances |
US20020035107A1 (en) | 2000-06-20 | 2002-03-21 | Stefan Henke | Highly concentrated stable meloxicam solutions |
DE10161077A1 (de) | 2001-12-12 | 2003-06-18 | Boehringer Ingelheim Vetmed | Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion |
US8992980B2 (en) | 2002-10-25 | 2015-03-31 | Boehringer Ingelheim Vetmedica Gmbh | Water-soluble meloxicam granules |
US20100297252A1 (en) | 2003-03-03 | 2010-11-25 | Elan Pharma International Ltd. | Nanoparticulate meloxicam formulations |
US8512727B2 (en) * | 2003-03-03 | 2013-08-20 | Alkermes Pharma Ireland Limited | Nanoparticulate meloxicam formulations |
EP1938803A3 (en) * | 2003-03-03 | 2010-10-27 | Elan Pharma International Limited | Formulations comprising nanoparticulate meloxican |
CA2521603A1 (en) * | 2003-04-07 | 2004-10-21 | Jurox Pty Ltd | Stable carprofen composition |
US20050158367A1 (en) * | 2004-01-16 | 2005-07-21 | The Procter & Gamble Company | Liquid compositions comprising one or more medicaments |
EP1568369A1 (en) | 2004-02-23 | 2005-08-31 | Boehringer Ingelheim Vetmedica Gmbh | Use of meloxicam for the treatment of respiratory diseases in pigs |
WO2006042381A1 (en) * | 2004-10-21 | 2006-04-27 | Parnell Laboratories (Aust) Pty Limited | Anti-inflammatory preparation |
AU2005313365A1 (en) | 2004-12-06 | 2006-06-15 | Janssen Pharmaceutica N.V. | Oral suspension comprising meloxicam |
GB2438287A (en) * | 2006-05-19 | 2007-11-21 | Norbrook Lab Ltd | Stable aqueous suspension |
EP2488145B1 (en) | 2009-10-12 | 2024-04-24 | Boehringer Ingelheim Vetmedica GmbH | Containers for compositions comprising meloxicam |
US9149480B2 (en) | 2010-03-03 | 2015-10-06 | Boehringer Ingeleheim Vetmedica GmbH | Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats |
US20110218191A1 (en) * | 2010-03-03 | 2011-09-08 | Boehringer Ingelheim Vetmedica Gmbh | Use of meloxicam for the long term-treatment of kidney disorders in cats |
WO2011110930A2 (en) * | 2010-03-10 | 2011-09-15 | Lupin Limited | Rifaximin ready-to-use suspension |
EP3295796A1 (en) * | 2010-03-19 | 2018-03-21 | 1Globe Biomedical Co., Ltd. | Novel compounds and compositions for targeting cancer stem cells |
US9795568B2 (en) | 2010-05-05 | 2017-10-24 | Boehringer Ingelheim Vetmedica Gmbh | Low concentration meloxicam tablets |
GB201117858D0 (en) | 2011-10-17 | 2011-11-30 | Norbrook Lab Ltd | Paste |
WO2014097685A1 (ja) * | 2012-12-19 | 2014-06-26 | 三菱電機株式会社 | 空気調和機 |
AU2016255437B2 (en) | 2015-04-28 | 2020-10-08 | Mars, Incorporated | Process of preparing a sterilized wet pet food product |
KR102145022B1 (ko) * | 2018-08-14 | 2020-08-14 | 동아제약 주식회사 | 이부프로펜의 현탁액 조성물 및 투여 제형 |
CN112044605B (zh) * | 2019-06-06 | 2022-06-21 | 钟志勇 | 选钛药剂及选钛方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1196307B (it) * | 1984-10-22 | 1988-11-16 | Chiesi Farma Spa | Formulazioni farmaceutiche acquose di piroxicam monoidrato |
US4835187A (en) * | 1987-06-15 | 1989-05-30 | American Home Products Corporation | Spray dried ibuprofen |
JP2860729B2 (ja) * | 1992-03-10 | 1999-02-24 | エスエス製薬株式会社 | プラノプロフェン懸濁シロップ剤 |
GB2318511A (en) * | 1996-10-23 | 1998-04-29 | Eurand Int | Process for the preparation of a pharmaceutical composition for rapid suspension in water |
-
1998
- 1998-03-27 EP EP98105568A patent/EP0945131A1/de not_active Withdrawn
-
1999
- 1999-03-04 TW TW088103315A patent/TWI232759B/zh not_active IP Right Cessation
- 1999-03-23 AT AT99913291T patent/ATE225648T1/de active
- 1999-03-23 JP JP2000540811A patent/JP3323189B2/ja not_active Expired - Lifetime
- 1999-03-23 TR TR2000/02772T patent/TR200002772T2/xx unknown
- 1999-03-23 PL PL342345A patent/PL192969B1/pl unknown
- 1999-03-23 AU AU31470/99A patent/AU762464B2/en not_active Expired
- 1999-03-23 KR KR1020007010684A patent/KR100587208B1/ko not_active IP Right Cessation
- 1999-03-23 EP EP99913291A patent/EP1066029B1/de not_active Expired - Lifetime
- 1999-03-23 NZ NZ507610A patent/NZ507610A/en not_active IP Right Cessation
- 1999-03-23 WO PCT/EP1999/001948 patent/WO1999049845A1/de active IP Right Grant
- 1999-03-23 HU HU0102036A patent/HU228474B1/hu unknown
- 1999-03-23 IL IL13747999A patent/IL137479A/xx not_active IP Right Cessation
- 1999-03-23 DE DE59903023T patent/DE59903023D1/de not_active Expired - Lifetime
- 1999-03-23 CA CA002326048A patent/CA2326048C/en not_active Expired - Lifetime
- 1999-03-23 BR BR9909189-5A patent/BR9909189A/pt not_active Application Discontinuation
- 1999-03-23 ES ES99913291T patent/ES2184428T3/es not_active Expired - Lifetime
- 1999-03-23 PT PT99913291T patent/PT1066029E/pt unknown
- 1999-03-23 CN CNB998044695A patent/CN1150888C/zh not_active Expired - Lifetime
- 1999-03-23 DK DK99913291T patent/DK1066029T3/da active
- 1999-03-24 UY UY25443A patent/UY25443A1/es not_active IP Right Cessation
- 1999-03-25 MY MYPI99001139A patent/MY124599A/en unknown
- 1999-03-26 CO CO99018550A patent/CO5070601A1/es unknown
- 1999-03-26 AR ARP990101338A patent/AR016196A1/es not_active Ceased/Invalidation/Refusal/Rejection/Nullification
-
2000
- 2000-08-03 ZA ZA200003951A patent/ZA200003951B/xx unknown
- 2000-09-26 NO NO20004822A patent/NO321401B1/no not_active IP Right Cessation
-
2001
- 2001-07-04 HK HK01104589A patent/HK1034184A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO5070601A1 (es) | Suspencion peroral de meloxicam micronizado que cuenta con bajas proporciones de dioxido de silicio y un polimero hidrofilico como hidroxietilcelulosa, en un medio de dispercion constituido por una solucion reguladora en un rango de ph de 2 a 4 | |
ES2612349T3 (es) | Derivados de tipo azaindazol o diazaindazol para tratar el dolor | |
CO5261605A1 (es) | Compustos farmaceuticos | |
UY29182A1 (es) | "derivados de bencenosulfonamidas sustituídas, composiciones que las contienen, procedimientos de preparación y aplicaciones" | |
AR051485A1 (es) | Pirazolo pirimidinas 1,4-sustituidas como inhibidores de quinasa | |
PA8638101A1 (es) | Inhibidores de cetp | |
EA003696B1 (ru) | Селективный в отношении цог-2 карпрофен для лечения боли и воспаления у собак | |
BRPI0606806A2 (pt) | compostos indólicos, suas composições e seus usos | |
AU2011222971B2 (en) | Use of meloxicam for the long-term treatment of kidney disorders in cats | |
CA2666036A1 (en) | Novel compositions and methods for treating hyperproliferative diseases | |
JP4588998B2 (ja) | 併用剤 | |
DK2368887T3 (da) | 1, 2, 3-triazolderivater til anvendelse som stearoyl-coa desaturase-inhibitorer | |
CA2358289A1 (en) | Amide derivatives for antiangiogenic and/or antitumorigenic use | |
HRP20090551T1 (hr) | Makrolidni konjugati s protuupalnom aktivnošću | |
RU2007119577A (ru) | Конъюгаты, обладающие противовоспалительной активностью | |
AU2002337105A1 (en) | Combination of a NSAID and a PDE-4 inhibitor | |
RU2016148183A (ru) | (s)-пирлиндол и его фармацевтические приемлемые соли для применения в медицине | |
US20040198826A1 (en) | Pharmaceutical combination for treating benign prostatic hyperplasia or for treating abacterial prostatitis | |
AR064865A1 (es) | Derivados de piridina antagonistas de p2y12 | |
Smelly et al. | COX‐LOX inhibition: Current evidence for an emerging new therapy | |
EP1613327A2 (en) | Pharmaceutical combination containing tamsulosin and a non-steroidal anti-inflammatory drug | |
DK1634595T3 (da) | N-Phenylbenzamidderivater som medikamenter til behandling af kronisk obstruktiv lungesygdom (KOL) | |
AR077297A1 (es) | Medicamento para uso prolongado de nsaid | |
DK1165444T3 (da) | Anvendelse af porphyrinderivater i akvarier | |
CR6503A (es) | Derivados de- 1-trifluorometil-4-hidroxi-7-piperidinil-aminometiclcromano |